| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/21/2003 | CA2236160C Method and composition for inhibiting growth of microorganisms including peracetic acid and a non-oxidizing biocide |
| 01/21/2003 | CA2130784C Plasmid derived from lactobacillus delbrueckii sp. |
| 01/21/2003 | CA2096529C Recombinant avirulent salmonella antifertility vaccines |
| 01/21/2003 | CA2063592C Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 01/21/2003 | CA1341417C Hirudine-expressing vectors, altered cells, and a process for hirudine preparation |
| 01/18/2003 | CA2352702A1 Novel human proton gated ion channel |
| 01/17/2003 | CA2407295A1 Transgenic non-human mammal |
| 01/16/2003 | WO2003004697A2 Method for detecting mutagenic substances |
| 01/16/2003 | WO2003004691A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004689A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004683A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | WO2003004680A2 Atherosclerosis susceptibility gene locus 1 (athsq1) and 2 (athsq2) |
| 01/16/2003 | WO2003004675A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004674A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004673A1 Process for the fermentative preparation of d-pantothenic acid and/or salts thereof |
| 01/16/2003 | WO2003004671A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004670A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced pts-g expression |
| 01/16/2003 | WO2003004669A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced mop-b expression |
| 01/16/2003 | WO2003004665A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004664A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced fba expression |
| 01/16/2003 | WO2003004663A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004662A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004659A2 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 01/16/2003 | WO2003004657A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004656A1 Method for obtaining cells with new properties |
| 01/16/2003 | WO2003004653A1 Method of modifying enzyme and oxidoreductase variant |
| 01/16/2003 | WO2003004652A2 Use of a tyrosine recombinase for genetic engineering |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004639A1 Dna fragments containing gene having function relating to autonomous proliferation of plasmid |
| 01/16/2003 | WO2003004636A2 Expression vectors encoding bacteriophage signal peptides |
| 01/16/2003 | WO2003004635A1 Novel aminopeptidase derived from bacillus licheniformis, gene encoding the aminopeptidase, expression vector containing the gene, transformant and method for preparation thereof |
| 01/16/2003 | WO2003004634A2 Carboxypeptidase of cocoa |
| 01/16/2003 | WO2003004620A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004615A2 Secreted proteins |
| 01/16/2003 | WO2003004613A2 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | WO2003004611A2 Human olfactory nucleotide-gated ion channels |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004607A2 Aggrecanase molecules |
| 01/16/2003 | WO2003004604A2 Phage displayed pdz domain ligands |
| 01/16/2003 | WO2003004598A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004525A2 Isolation and purification of plasmodium falciparum merozoite protein-142 |
| 01/16/2003 | WO2003004520A2 Mycobacterial antigens expressed during latency |
| 01/16/2003 | WO2003004066A1 Gene therapeutics |
| 01/16/2003 | WO2003004052A1 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| 01/16/2003 | WO2003003979A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | WO2003003906A2 Diagnostic and screening methods for bladder cancer |
| 01/16/2003 | WO2002088178A3 Antigens of group b streptococcus and corresponding dna fragments |
| 01/16/2003 | WO2002077023A3 A new essential downstream component of the wingless signalling pathway |
| 01/16/2003 | WO2002070724A3 Method of preparing 2-deoxyribose 5-phosphate |
| 01/16/2003 | WO2002053724A3 Enzymatic deprotection of amines and hydroxides |
| 01/16/2003 | WO2002046362A3 Gene associated with benign prostatic hyperplasia in humans |
| 01/16/2003 | WO2002043661A3 Recombinant anti-cd30 antibodies and uses thereof |
| 01/16/2003 | WO2002029030A3 Ethanol production |
| 01/16/2003 | WO2002026819A3 Recombinant bcg vaccines for the prevention and treatment of cancer |
| 01/16/2003 | WO2002022806A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 01/16/2003 | WO2002020813A3 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 01/16/2003 | WO2002020727A3 Method for propagating fungi using solid state fermentation |
| 01/16/2003 | WO2002018609A3 Methods for stable transduction of cells with viral vectors |
| 01/16/2003 | WO2002016595A3 Kidney-specific protein |
| 01/16/2003 | WO2002016587A3 Microtubule-associated proteins and tubulins |
| 01/16/2003 | WO2002010406A3 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 01/16/2003 | WO2002006503A3 Process for generation of hydrogen gas from various feedstocks using thermophilic bacteria |
| 01/16/2003 | WO2002002783A3 Expression vectors |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2002002604A3 Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001092539A3 Method for the production of p-hydroxybenzoate in species of pseudomonas and agrobacterium |
| 01/16/2003 | WO2001092490A3 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001087937A3 G-protein coupled receptors |
| 01/16/2003 | WO2001077153A3 Phage display selection of anti fungal peptides |
| 01/16/2003 | WO2001070174A8 Vegf-modulated genes and methods employing them |
| 01/16/2003 | WO2001068880A9 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | US20030013867 Translation enhancer element of the human amyloid precursor protein gene |
| 01/16/2003 | US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013755 Autoinducer compounds |
| 01/16/2003 | US20030013662 Novel polyketide derivatives and recombinant methods for making same |
| 01/16/2003 | US20030013636 Prevent biosynthesis of galactoside |
| 01/16/2003 | US20030013181 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 01/16/2003 | US20030013180 Pullulanase for use in saccharfication of stsrches |
| 01/16/2003 | US20030013175 Enzymatic polypetide for use in modifying carbohydrates |
| 01/16/2003 | US20030013174 Genes for lysine biosynthetic system derived from thermophilic bacteria |
| 01/16/2003 | US20030013163 Method and device for producing shaped microbial cellulose for use as a biomaterial, especially for microsurgery |
| 01/16/2003 | US20030013162 Interferon-epsilon |
| 01/16/2003 | US20030013149 Quantitative analysis |
| 01/16/2003 | US20030013139 Transgenic cells for use as diagnostic tools in genetic engineering |
| 01/16/2003 | US20030013132 Non-invasive localization of a light-emitting conjugate in a mammal |
| 01/16/2003 | US20030013108 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 01/16/2003 | US20030013102 D-hydantoinase from Ochrobactrum anthropi |
| 01/16/2003 | US20030013095 Nuclcic acid enzyme for use in the prevention and treatment of infections and cancer |
| 01/16/2003 | US20030013087 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/16/2003 | US20030013078 Expression vector for use in the prevention and treatment of vial infection |
| 01/16/2003 | US20030012819 Method of preparing biological materials and preparations produced using same |
| 01/16/2003 | US20030012795 Treating peripheral resistance in a mammal; modulating the immune response in a mammal |
| 01/16/2003 | US20030010712 Process for biochemical treatment of waste water using nano materials |
| 01/16/2003 | CA2467006A1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | CA2462951A1 Isolation and purification of plasmodium falciparum merozoite protein-142 |